PMDA — authorised 26 December 2014
- Marketing authorisation holder: Nippon Boehringer Ingelheim Co., Ltd
- Status: approved
PMDA authorised Jardiance on 26 December 2014
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. PMDA authorised it on 26 December 2014.
Nippon Boehringer Ingelheim Co., Ltd holds the Japanese marketing authorisation.